Jones, Peter, Storer, Ian, Sabnis, Yogesh A., Wakenhut, Florian M., Whitlock, Gavin A., England, Katherine S., Mukaiyama, Takasuke, Dehnhardt, Christoph M., Coe, Jotham W., Kortum, Steve W., and others. (2016) Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin. Journal of Medicinal Chemistry, 60 (2). pp. 767-786. ISSN 0022-2623. (doi:10.1021/acs.jmedchem.6b01634) (KAR id:60028)
PDF
Author's Accepted Manuscript
Language: English |
|
Download this file (PDF/1MB) |
Preview |
Request a format suitable for use with assistive technology e.g. a screenreader | |
Official URL: http://dx.doi.org/10.1021/acs.jmedchem.6b01634 |
Abstract
By use of a structure-based computational method for identification of structurally novel Janus kinase (JAK) inhibitors predicted to bind beyond the ATP binding site, a potent series of indazoles was identified as selective pan-JAK inhibitors with a type 1.5 binding mode. Optimization of the series for potency and increased duration of action commensurate with inhaled or topical delivery resulted in potent pan-JAK inhibitor 2 (PF-06263276), which was advanced into clinical studies.
Item Type: | Article |
---|---|
DOI/Identification number: | 10.1021/acs.jmedchem.6b01634 |
Uncontrolled keywords: | Structure Based Drug Design JAK inhibitors |
Subjects: | Q Science > QD Chemistry > QD431 Organic Chemistry- Biochemistry- Proteins, peptides, amino acids |
Divisions: | Divisions > Division of Natural Sciences > Biosciences |
Depositing User: | David Brown |
Date Deposited: | 23 Jan 2017 13:46 UTC |
Last Modified: | 05 Nov 2024 10:52 UTC |
Resource URI: | https://kar.kent.ac.uk/id/eprint/60028 (The current URI for this page, for reference purposes) |
- Link to SensusAccess
- Export to:
- RefWorks
- EPrints3 XML
- BibTeX
- CSV
- Depositors only (login required):